REVITACARE

Revitacare, founded in 2003 and headquartered in Saint-Ouen-l'Aumône, France, is a prominent laboratory specializing in the research, development, and production of medical devices and cosmetic products based on hyaluronic acid. The company is renowned for its innovative solutions aimed at preventing and correcting skin aging and treating hair problems. Revitacare's product portfolio includes the acclaimed Cytocare line, which is widely recognized for its efficacy in skin rejuvenation and hydration. Other notable products include Haircare, a treatment designed to promote hair growth, and Revitafill Xtra, a line of monophasic fillers with amino acids. These products are developed using exclusive components of active ingredients, ensuring high performance and safety. In 2017, Revitacare was acquired by Bloomage Biotech, a leading Chinese company in hyaluronic acid production. This acquisition has expanded Revitacare's reach and enhanced its product offerings, allowing for greater distribution and innovation in the global market. The company remains committed to quality, with ISO 13485 certification ensuring that its products meet stringent regulatory standards.